Triple Antibiotic
- Product NDC
- 47682-392
- 11-digit product format
- 476820392
- Labeler code
- 47682
- Product ID
- 47682-392_3e4ee639-9af3-38c5-e063-6394a90a9ad3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- bacitracin zinc, neomycin sulfate, polymyxin b sulfate
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- Unifirst First Aid Corporation
- Application
- M004
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2013-04-12
- Substance
- BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
- Active strength
- 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g
- Pharmacologic classes
- Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 47682-392 | 47682-392-12 | D | Discontinued by firm | 2026-10-15 | |
| excluded package | package | 47682-392 | 47682-392-71 | D | Discontinued by firm | 2026-10-15 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 47682-392-12 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 47682-392-71 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 47682-392-71 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 47682-392-12 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 47682-392-71 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 47682-392-12 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 47682-392-71 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 47682-392-12 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 47682-392-71 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 47682-392-12 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 47682-392-71 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 47682-392-12 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 47682-392-71 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 47682-392-12 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 47682-392-71 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 47682-392-12 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 47682-392-71 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 47682-392-12 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 47682-392-71 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 47682-392-12 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 47682-392-71 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 47682-392-12 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 47682-392-71 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 47682-392-12 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Triple Antibiotic
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BACITRACIN ZINC | 400 [USP'U]/g |
| NEOMYCIN SULFATE | 3.5 mg/g |
| POLYMYXIN B SULFATE | 5000 [USP'U]/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 89Y4M234ES | Internal UNII lookup |
| 057Y626693 | Internal UNII lookup |
| 19371312D4 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 204602 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| d7c1a10e-c38d-4ae8-9a27-c07c2208ca84 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 99e684e6-f435-feb8-d2bb-3a546f1cb768 | Product name | 2 | 20161117 |
| 25340b3b-3e4c-4ff8-abf6-3e62ec46bd0c | Product name | 1 | 20160603 |
| 2d352c73-a357-4193-a4de-dfdf9a2ac8e4 | Product name | 1 | 20150819 |
| b045ad64-0f28-9a02-2f9b-b34d94fb2278 | Product name | 1 | 20140508 |
| b6082387-f592-1148-0844-bd068fd213fb | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 47682-392-12 | Triple Antibiotic | 0.5 g in 1 PACKET | OINTMENT | 0.5 | 14 | |
| 47682-392-12 | Triple Antibiotic | 10 in 1 BOX | OINTMENT | 10 | 14 | |
| 47682-392-35 | Triple Antibiotic | 0.5 g in 1 PACKET | OINTMENT | 0.5 | 14 | |
| 47682-392-35 | Triple Antibiotic | 144 in 1 BAG | OINTMENT | 144 | 14 | |
| 47682-392-71 | Triple Antibiotic | 0.5 g in 1 PACKET | OINTMENT | 0.5 | 14 | |
| 47682-392-71 | Triple Antibiotic | 20 in 1 BOX | OINTMENT | 20 | 14 | |
| 47682-392-73 | Triple Antibiotic | 25 in 1 BOX, UNIT-DOSE | OINTMENT | 25 | 14 | |
| 47682-392-99 | Triple Antibiotic | 0.5 g in 1 PACKET | OINTMENT | 0.5 | 14 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 47682-392 | TRIPLE ANTIBIOTIC (BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE) OINTMENT [UNIFIRST FIRST AID CORPORATION] | 13 | Current NDC, Legacy NDC, 8 package rows | 20250210_d7c1a10e-c38d-4ae8-9a27-c07c2208ca84.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triple Antibiotic First Aid Antibiotic | BACITRACIN ZINC, NEOMYCIN AND POLYMYXIN B SULFATE | Universal Distribution Center LLC | 78f00296-267b-44c3-a9e3-c40f122e905e | 2024-05-14 | Warnings | M004 |
| TRIPLE ANTIBIOTIC | BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE | JHK Inc dba American Safety & First Aid | 26e66025-9457-42b3-9319-51302c17506e | 2024-04-26 | Warnings | M004 |
| Hydrogen Peroxide | HYDROGEN PEROXIDE | JHK Inc | 1472c854-09c8-4ad8-b8a6-0235440ac26b | 2024-04-26 | Warnings | M004 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | JHK Inc | abae6a80-e859-47b5-8e34-d391eb854583 | 2024-04-26 | Warnings | M004 |
| Antiseptic | BENZALKONIUM CHLORIDE, BENZOCAINE | JHK Inc | 0ac5d890-c262-4a30-9fd8-2de6cb0f7601 | 2024-04-25 | Warnings | M004 |
| First Aid Antibiotic Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | M-star (Hubei) Health&Care Products Co., Ltd. | c6f2656e-b822-4d61-b557-dd2046dd51f5 | 2024-04-01 | Warnings | M004 |
| Antibiotic | BACITRACIN ZINC, POLYMYXIN B SULFATE | CVS PHARMACY, INC | 32e92acf-2e48-4933-8e08-e1df650e7d19 | 2024-03-15 | Warnings | M004 |
| Major Bacitracin | BACITRACIN | Major Pharmaceuticals | 13288efb-e282-68f8-e063-6294a90ae712 | 2024-03-08 | Warnings | M004 |
| UniShield TRIPLE ANTIBIOTIC | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Unishield | 00b85d3a-322b-43c1-b022-5f6ed50c6609 | 2024-03-02 | Warnings | M004 |
| Triple Antibiotic Plus Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Chain Drug Marketing Association Inc. | 1277942d-753f-ab69-e063-6394a90a496a | 2024-02-28 | Warnings | M004 |
| Triple Antibiotic with Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HYDROCHLORIDE | Safetec of America, Inc. | ca1df4a0-844d-4b1d-b972-f2704a8ebbab | 2024-02-16 | Warnings | M004 |
| Single Antibiotic | BACITRACIN ZINC | Safetec of America, Inc. | 9993c204-6e61-4da3-90ef-2b7dfa09c920 | 2024-02-14 | Warnings | M004 |
| Single Antibiotic with Neomycin | NEOMYCIN SULFATE | Safetec of America | e989cf7e-f3d1-42d2-af45-fc80095b97cb | 2024-02-08 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Safetec of America, Inc. | 96c41fc1-81f9-4757-abc6-867b5383ed5d | 2024-02-07 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Safetec of America, Inc. | 2c2aa8af-2adb-4f59-ac20-15818d0e28e7 | 2024-02-07 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Safetec of America, Inc. | 03c05028-5a5f-4690-a836-cc1b1044ab39 | 2024-02-05 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Safetec of America, Inc. | 59494d5c-dd8a-431c-8e6a-4e1151ba7460 | 2024-02-05 | Warnings | M004 |
| Triple Antibiotic | FIRST AID ANTIBIOTIC | BluePoint Laboratories | c47e15bd-1062-4cca-e053-2995a90a9075 | 2024-01-31 | Warnings | M004 |
| Neomycin | NEOMYCIN OINTMENT | Dynarex Corporation | 0f9e087b-6e86-a3c7-e063-6394a90ac8d4 | 2024-01-23 | Warnings | M004 |
| Antibiotic and Pain Relief | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | Target Corporation | 050be94c-1fbb-4d84-82c6-841aac8f318e | 2024-01-18 | Warnings | M004 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 204602 | bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment | PSN | d7c1a10e-c38d-4ae8-9a27-c07c2208ca84 | 14 |
| 204602 | bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment | SCD | d7c1a10e-c38d-4ae8-9a27-c07c2208ca84 | 14 |
| 204602 | bacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical Ointment | SY | d7c1a10e-c38d-4ae8-9a27-c07c2208ca84 | 14 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 47682-392-12 | 47682039212 | 0.5 g in 1 PACKET | 0.5 g | Historical | ||||
| 47682-392-35 | 47682039235 | 144 PACKET in 1 BAG (47682-392-35) / .5 g in 1 PACKET | 144 packet | 2017-06-30 | 0000-00-00 | No | No | Current |
| 47682-392-71 | 47682039271 | 0.5 g in 1 PACKET | 0.5 g | Historical | ||||
| 47682-392-73 | 47682039273 | 25 PACKET in 1 BOX, UNIT-DOSE (47682-392-73) / .5 g in 1 PACKET (47682-392-99) | 25 packet | 2016-06-06 | 0000-00-00 | No | No | Current |
| 47682-392-99 | 47682039299 | .5 g in 1 PACKET (47682-392-99) | 2013-04-12 | No | No | Current |